O'Connor OA - Search Results

1

Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?

Portlock CS, O'Connor OA, Straus DJ, Rosenzweig L, Dumitrescu O, Lin O, Maslak P. Portlock CS, et al. Leuk Lymphoma. 2006 Jul;47(7):1260-4. doi: 10.1080/10428190600565354. Leuk Lymphoma. 2006. PMID: 16923555

2

Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.

Wang ES, O'Connor O, She Y, Zelenetz AD, Sirotnak FM, Moore MA. Wang ES, et al. Leuk Lymphoma. 2003 Jun;44(6):1027-35. doi: 10.1080/1042819031000077124. Leuk Lymphoma. 2003. PMID: 12854905

3

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.

Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O'Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH. Kewalramani T, et al. Blood. 2004 May 15;103(10):3684-8. doi: 10.1182/blood-2003-11-3911. Epub 2004 Jan 22. Blood. 2004. PMID: 14739217 Free article. Clinical Trial.

4

Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease.

Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, Noy A, O'Connor O, Horwitz S, Moskowitz C, Filippa DA. Portlock CS, et al. Br J Haematol. 2004 Jun;125(6):701-8. doi: 10.1111/j.1365-2141.2004.04964.x. Br J Haematol. 2004. PMID: 15180859 Free article.

5

Diffuse aggressive lymphoma.

Fisher RI, Miller TP, O'Connor OA. Fisher RI, et al. Hematology Am Soc Hematol Educ Program. 2004:221-36. doi: 10.1182/asheducation-2004.1.221. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561685 Review.

6

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

O'Connor OA, Wright J, Moskowitz C, Muzzy J, MacGregor-Cortelli B, Stubblefield M, Straus D, Portlock C, Hamlin P, Choi E, Dumetrescu O, Esseltine D, Trehu E, Adams J, Schenkein D, Zelenetz AD. O'Connor OA, et al. J Clin Oncol. 2005 Feb 1;23(4):676-84. doi: 10.1200/JCO.2005.02.050. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613699 Clinical Trial.

7

Developing new drugs for the treatment of lymphoma.

O'Connor OA. O'Connor OA. Eur J Haematol Suppl. 2005 Jul;(66):150-8. doi: 10.1111/j.1600-0609.2005.00470.x. Eur J Haematol Suppl. 2005. PMID: 16007885 Review.

8

R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.

Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, O'Connor OA, Yahalom J, Zelenetz AD. Halaas JL, et al. Leuk Lymphoma. 2005 Apr;46(4):541-7. doi: 10.1080/10428190400029932. Leuk Lymphoma. 2005. PMID: 16019482 Clinical Trial.

9

Comparative animal models for the study of lymphohematopoietic tumors: strengths and limitations of present approaches.

O'Connor OA, Toner LE, Vrhovac R, Budak-Alpdogan T, Smith EA, Bergman P. O'Connor OA, et al. Leuk Lymphoma. 2005 Jul;46(7):973-92. doi: 10.1080/10428190500083193. Leuk Lymphoma. 2005. PMID: 16019548 Review.

10

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.

Hamlin PA, Portlock CS, Straus DJ, Noy A, Singer A, Horwitz SM, Oconnor OA, Yahalom J, Zelenetz AD, Moskowitz CH. Hamlin PA, et al. Br J Haematol. 2005 Sep;130(5):691-9. doi: 10.1111/j.1365-2141.2005.05661.x. Br J Haematol. 2005. PMID: 16115124 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters